(+)-pilocarpine decreases expression EXP 6480464 Pilocarpine results in decreased expression of BCL10 mRNA CTD PMID:17971868 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of BCL10 mRNA CTD PMID:17971868 (1->4)-beta-D-glucan multiple interactions ISO RGD:733736 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BCL10 mRNA CTD PMID:36331819 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o, p'-DDT results in decreased expression of BCL10 mRNA CTD PMID:22937105 1,2-dimethylhydrazine multiple interactions ISO RGD:733736 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BCL10 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:733736 6480464 1, 2-Dimethylhydrazine results in decreased expression of BCL10 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of BCL10 mRNA CTD PMID:30723492 1H-pyrazole increases expression ISO RGD:733736 6480464 pyrazole results in increased expression of BCL10 mRNA CTD PMID:17945193 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733736 6480464 Tetrachlorodibenzodioxin affects the expression of BCL10 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL10 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL10 mRNA CTD PMID:34747641 2-hydroxypropanoic acid increases expression ISO RGD:1347575 6480464 Lactic Acid results in increased expression of BCL10 mRNA CTD PMID:30851411 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of BCL10 mRNA CTD PMID:19643169 3-methylcholanthrene multiple interactions ISO RGD:733736 6480464 [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of BCL10 mRNA CTD PMID:25926378 acrylamide increases expression ISO RGD:1347575 6480464 Acrylamide results in increased expression of BCL10 mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO RGD:1347575 6480464 Aflatoxin B1 results in increased methylation of BCL10 gene CTD PMID:27153756 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of BCL10 protein CTD PMID:16483693 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BCL10 mRNA CTD PMID:16483693 aripiprazole multiple interactions ISO RGD:1347575 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of BCL10 mRNA CTD PMID:31476115 arsane increases expression ISO RGD:1347575 6480464 Arsenic results in increased expression of BCL10 mRNA CTD PMID:19945496 , PMID:31739468 arsane multiple interactions ISO RGD:1347575 6480464 [Arsenic co-treated with Iron] results in increased expression of BCL10 mRNA CTD PMID:31739468 arsenic atom increases expression ISO RGD:1347575 6480464 Arsenic results in increased expression of BCL10 mRNA CTD PMID:19945496 , PMID:31739468 arsenic atom multiple interactions ISO RGD:1347575 6480464 [Arsenic co-treated with Iron] results in increased expression of BCL10 mRNA CTD PMID:31739468 arsenous acid increases expression ISO RGD:1347575 6480464 Arsenic Trioxide results in increased expression of BCL10 mRNA CTD PMID:17530438 benzo[a]pyrene decreases expression ISO RGD:733736 6480464 Benzo(a)pyrene results in decreased expression of BCL10 mRNA CTD PMID:20127859 benzo[a]pyrene increases expression ISO RGD:1347575 6480464 Benzo(a)pyrene results in increased expression of BCL10 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:1347575 6480464 Benzo(a)pyrene results in decreased methylation of BCL10 promoter CTD PMID:27901495 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BCL10 mRNA CTD PMID:25181051 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of BCL10 mRNA CTD PMID:33453195 calcitriol multiple interactions ISO RGD:1347575 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of BCL10 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1347575 6480464 Calcitriol results in increased expression of BCL10 mRNA CTD PMID:21592394 capsaicin increases expression ISO RGD:1347575 6480464 Capsaicin results in increased expression of BCL10 mRNA CTD PMID:19502594 carbon nanotube increases expression ISO RGD:733736 6480464 Nanotubes, Carbon results in increased expression of BCL10 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:733736 6480464 Nanotubes, Carbon results in decreased expression of BCL10 mRNA CTD PMID:25926378 carbon nanotube multiple interactions ISO RGD:733736 6480464 [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of BCL10 mRNA CTD PMID:25926378 carmustine increases expression ISO RGD:1347575 6480464 Carmustine results in increased expression of BCL10 mRNA CTD PMID:15980968 cisplatin increases expression ISO RGD:1347575 6480464 Cisplatin results in increased expression of BCL10 mRNA CTD PMID:27392435 cobalt dichloride increases expression ISO RGD:1347575 6480464 cobaltous chloride results in increased expression of BCL10 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1347575 6480464 [Chelating Agents binds to Copper] which results in increased expression of BCL10 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1347575 6480464 [Chelating Agents binds to Copper] which results in increased expression of BCL10 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:1347575 6480464 Copper Sulfate results in increased expression of BCL10 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1347575 6480464 Asbestos, Crocidolite results in increased expression of BCL10 mRNA CTD PMID:18687144 curcumin multiple interactions ISO RGD:1347575 6480464 Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of BCL10 mRNA] CTD PMID:23452621 cyclosporin A increases expression ISO RGD:1347575 6480464 Cyclosporine results in increased expression of BCL10 mRNA CTD PMID:20106945 , PMID:25562108 deoxynivalenol increases expression ISO RGD:1347575 6480464 deoxynivalenol results in increased expression of BCL10 mRNA CTD PMID:22846391 diarsenic trioxide increases expression ISO RGD:1347575 6480464 Arsenic Trioxide results in increased expression of BCL10 mRNA CTD PMID:17530438 dibutyl phthalate increases expression ISO RGD:733736 6480464 Dibutyl Phthalate results in increased expression of BCL10 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of BCL10 mRNA CTD PMID:21266533 dioxygen multiple interactions ISO RGD:1347575 6480464 3 more ... CTD PMID:23452621 dioxygen multiple interactions ISO RGD:733736 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of BCL10 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:1347575 6480464 Oxygen deficiency results in increased expression of BCL10 mRNA CTD PMID:23452621 diquat decreases expression ISO RGD:733736 6480464 Diquat results in decreased expression of BCL10 protein CTD PMID:36851058 doxorubicin decreases expression ISO RGD:1347575 6480464 Doxorubicin results in decreased expression of BCL10 mRNA CTD PMID:29803840 ethanol multiple interactions ISO RGD:733736 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of BCL10 mRNA CTD PMID:30517762 ethyl methanesulfonate increases expression ISO RGD:1347575 6480464 Ethyl Methanesulfonate results in increased expression of BCL10 mRNA CTD PMID:23649840 fluoranthene multiple interactions ISO RGD:733736 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL10 mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:733736 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BCL10 mRNA CTD PMID:22206623 folic acid decreases expression ISO RGD:733736 6480464 Folic Acid results in decreased expression of BCL10 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1347575 6480464 Formaldehyde results in increased expression of BCL10 mRNA CTD PMID:23649840 furan increases expression EXP 6480464 furan results in increased expression of BCL10 mRNA CTD PMID:20562052 , PMID:22079235 furosemide affects expression EXP 6480464 Furosemide affects the expression of BCL10 mRNA CTD PMID:17497460 genistein decreases expression ISO RGD:733736 6480464 Genistein results in decreased expression of BCL10 mRNA CTD PMID:24967385 genistein multiple interactions ISO RGD:1347575 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of BCL10 mRNA] CTD PMID:23452621 genistein increases expression ISO RGD:1347575 6480464 Genistein results in increased expression of BCL10 mRNA CTD PMID:26865667 genistein increases expression ISO RGD:733736 6480464 Genistein results in increased expression of BCL10 mRNA CTD PMID:22553218 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BCL10 mRNA CTD PMID:22061828 , PMID:33387578 glyphosate decreases expression EXP 6480464 glyphosate results in decreased expression of BCL10 mRNA CTD PMID:26302742 hydrogen peroxide affects expression ISO RGD:1347575 6480464 Hydrogen Peroxide affects the expression of BCL10 protein CTD PMID:21179406 iron atom multiple interactions ISO RGD:1347575 6480464 [Arsenic co-treated with Iron] results in increased expression of BCL10 mRNA CTD PMID:31739468 iron(0) multiple interactions ISO RGD:1347575 6480464 [Arsenic co-treated with Iron] results in increased expression of BCL10 mRNA CTD PMID:31739468 ivermectin decreases expression ISO RGD:1347575 6480464 Ivermectin results in decreased expression of BCL10 protein CTD PMID:32959892 lead diacetate increases expression ISO RGD:733736 6480464 lead acetate results in increased expression of BCL10 mRNA CTD PMID:20542052 methyl methanesulfonate increases expression ISO RGD:1347575 6480464 Methyl Methanesulfonate results in increased expression of BCL10 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1347575 6480464 methylmercuric chloride results in decreased expression of BCL10 mRNA CTD PMID:28001369 Myrtucommulone A decreases expression ISO RGD:733736 6480464 myrtucommulone A results in decreased expression of BCL10 mRNA CTD PMID:26032814 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of BCL10 mRNA CTD PMID:17412507 N-nitrosodiethylamine increases expression ISO RGD:733736 6480464 Diethylnitrosamine results in increased expression of BCL10 mRNA CTD PMID:24535843 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of BCL10 mRNA CTD PMID:22546817 nitrates increases expression EXP 6480464 Nitrates results in increased expression of BCL10 mRNA CTD PMID:30022042 o-anisidine affects expression ISO RGD:1347575 6480464 2-anisidine affects the expression of BCL10 mRNA CTD PMID:28089782 ozone increases expression ISO RGD:1347575 6480464 Ozone results in increased expression of BCL10 mRNA CTD PMID:31476115 ozone multiple interactions ISO RGD:1347575 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of BCL10 mRNA CTD PMID:31476115 p-menthan-3-ol decreases expression ISO RGD:1347575 6480464 Menthol results in decreased expression of BCL10 mRNA CTD PMID:26760959 paracetamol affects expression ISO RGD:733736 6480464 Acetaminophen affects the expression of BCL10 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BCL10 mRNA CTD PMID:33387578 paraquat decreases expression ISO RGD:1347575 6480464 Paraquat results in decreased expression of BCL10 mRNA CTD PMID:18836921 pentobarbital decreases expression EXP 6480464 Pentobarbital results in decreased expression of BCL10 mRNA CTD PMID:16978161 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:733736 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BCL10 mRNA CTD PMID:36331819 phenobarbital affects expression ISO RGD:1347575 6480464 Phenobarbital affects the expression of BCL10 mRNA CTD PMID:19159669 phosgene affects expression ISO RGD:733736 6480464 Phosgene affects the expression of BCL10 mRNA CTD PMID:16300373 pirinixic acid increases expression ISO RGD:733736 6480464 pirinixic acid results in increased expression of BCL10 mRNA CTD PMID:18301758 rac-lactic acid increases expression ISO RGD:1347575 6480464 Lactic Acid results in increased expression of BCL10 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:1347575 6480464 resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL10 mRNA] CTD PMID:23452621 silicon dioxide increases expression ISO RGD:733736 6480464 Silicon Dioxide results in increased expression of BCL10 mRNA CTD PMID:19073995 sulforaphane multiple interactions ISO RGD:733736 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of BCL10 mRNA CTD PMID:30529165 testosterone increases expression ISO RGD:1347575 6480464 Testosterone results in increased expression of BCL10 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1347575 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of BCL10 mRNA CTD PMID:21592394 tetrachloromethane multiple interactions ISO RGD:733736 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of BCL10 mRNA CTD PMID:30517762 tetrachloromethane increases expression ISO RGD:733736 6480464 Carbon Tetrachloride results in increased expression of BCL10 mRNA CTD PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of BCL10 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BCL10 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:733736 6480464 titanium dioxide results in decreased expression of BCL10 mRNA CTD PMID:29264374 Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of BCL10 mRNA CTD PMID:17553608 Tributyltin oxide increases expression ISO RGD:733736 6480464 bis(tri-n-butyltin)oxide results in increased expression of BCL10 mRNA CTD PMID:22434021 triptonide increases expression ISO RGD:733736 6480464 triptonide results in increased expression of BCL10 mRNA CTD PMID:33045310 valproic acid affects expression ISO RGD:733736 6480464 Valproic Acid affects the expression of BCL10 mRNA CTD PMID:17292431 valproic acid decreases expression ISO RGD:733736 6480464 Valproic Acid results in decreased expression of BCL10 mRNA CTD PMID:19136453 valproic acid increases expression ISO RGD:733736 6480464 Valproic Acid results in increased expression of BCL10 mRNA CTD PMID:21427059 vancomycin decreases expression ISO RGD:733736 6480464 Vancomycin results in decreased expression of BCL10 mRNA CTD PMID:18930951 zinc atom multiple interactions ISO RGD:1347575 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of BCL10 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1347575 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of BCL10 mRNA CTD PMID:18593933